Study of Unani Medicine in Bronchial Asthma
Phase 2
- Conditions
- Health Condition 1: J454- Moderate persistent asthma
- Registration Number
- CTRI/2024/05/068155
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Age between 18-50 years.
2) All gender.
3) Bronchial asthma of mild (FEV1 more than 70%) to moderate severity
(FEV1 60-69%) of predicted.
4) Patients ready to give consent for the study
Exclusion Criteria
1) Patients below 18 and above 50 years of age.
2) FEV1 less than 60% of predicted in spirometry.
3) Patients with systemic illness such as HTN, IHD, DM, Thyroid disorders, etc.
4) Patients with a history of allergic rhinitis, emphysema, chronic bronchitis, pneumonia, pneumoconiosis, pulmonary tuberculosis.
5) Severe anemia.
6) Pregnant and lactating women.
7) Patients who had received corticosteroids, bronchodilators or CAM therapy within 2 weeks prior to enrollment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method